Atlas Trials

Clinical Study of YQ1 Plus Cisplatin-based Chemotherapy in Advanced NSCLC EGFR Wild Type

Clinical trial NCT02967497 · UNKNOWN

Trial details

NCT number
NCT02967497
Sponsor
Taipei Veterans General Hospital, Taiwan
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Epithelial Growth Factor Receptor Negative Non-small Cell Lung Cancer
Start date
2016-10-01
Primary completion
2017-09-01
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.